Re: Six Ten @ MIT | 610 Main Street, Cambridge
MIT begins building Pfizer facility
Research at Kendall Square site will focus on drugs for diabetes, Alzheimer’s
By Casey Ross | GLOBE STAFF NOVEMBER 19, 2011
Pfizer Inc. on Monday will add its name to an ever-growing list of corporate giants expanding research operations near the Massachusetts Institute of Technology, as it kicks off construction of a new complex in Kendall Square.
The company will move into a 230,000-square-foot building that MIT is building at 610 Main St., where it will conduct research on drugs for type 2 diabetes, Alzheimer’s, and schizophrenia, among other illnesses. About 400 employees will work in the building.
“The objective is to take advantage of a revolution going on in biology and make better decisions about the therapeutic targets we’re working on,’’ said Rod MacKenzie, vice president of research and development for Pfizer. “When you’re dealing with really big medical problems like diabetes and Alzheimer’s, it takes a lot of people coming together to make an impact.’’
Pfizer is the latest of several large biotechnology companies looking to tap the deep reservoir of scientific talent in Kendall Square. Biogen Idec is expanding its office and research complex in the area, and early next year Novartis AG is scheduled to begin a $600 million facility next to MIT. In addition to its roster of pharmaceutical companies, Kendall Square also hosts offices for Google Inc., Microsoft Corp., and a wide range of technology start-ups.
MIT officials said that once the Pfizer building is completed in late 2013, they intend to develop a second building at 610 Main St. Together the buildings will contain about 500,000 square feet of office and lab space, along with retail stores at street level. The complex is expected to cost about $300 million.
In addition to the commercial development, MIT is also planning $1.5 billion in upgrades to its campus in coming years, including several new academic buildings. In recent decades, the university has gradually redeveloped many of the old industrial buildings around Kendall Square, beginning a transformation to a burgeoning mixed-use neighborhood with offices, homes, and a growing list of retailers and restaurants.
University officials said the work is central to creating an environment attractive to the world’s leading companies and researchers. “If we do it right, we will build powerful innovation cluster,’’ said Steve Marsh, managing director of real estate for MIT. “We have huge momentum in that area right now.’’
Link